- Home
- Mutual Funds
- Tata Mutual Fund
- Tata India Pharma & Healthcare Fund Direct-Growth
Fund Overview of Tata India Pharma & Healthcare Fund Direct-Growth
-
₹1,511.5 CrAUM
-
₹38.70NAV
-
1.10%Expense Ratio
-
EquityFund Category
As on Thu Nov 05, 2026
Calculate your Returns
How much do you want to invest monthly?
₹
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
The total value of your investment
after 10 years will be
₹ 1,39,328.64
Tata India Pharma & Healthcare Fund Direct-Growth Return Comparison
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | -3.21% | NA | 6.12% |
| 6 Months | 7.44% | NA | 12.92% |
| 1 Year | 6.72% | 6.72% | 6.04% |
| 2 Years | 9.74% | 4.76% | 24.93% |
| 3 Years | 71.06% | 19.60% | 25.71% |
| 5 Years | 102.86% | 15.20% | 19.91% |
| 7 Years | 298.27% | 21.83% | NA |
| 10 Years | 326.51% | 15.61% | 12.78% |
View More
As on Thu Nov 05, 2026
Asset Allocation of Tata India Pharma & Healthcare Fund Direct-Growth
equities
99.49%other assets or cash equivalents
0.51%Large Cap: 26.08%
Mid Cap: 34.56%
Small Cap: 39.36%
Other: 0.00%
Detailed Portfolio Analysis
As on Thu Nov 05, 2026
Invest Now
Tata India Pharma & Healthcare Fund Direct-Growth is one Equity mutual fund offered by Tata Mutual Fund. Launched on 28 Dec 2015, the fund aims Long Term Capital Appreciation. Investment in equity/equity related instruments of the companies in the Pharma & Healthcare sector in India. It manages assets worth ₹1,511.5 crore as on Wed Sep 30, 2026. The expense ratio stands at 1.1%. Fund Manager Manager Education
About FundAbout Tata India Pharma & Healthcare Fund Direct-Growth
The portfolio allocation consists of 99.49% in equities, 0.51% in other assets or cash equivalents.Managed by Rajat Srivastava, it has delivered a return of 6.72% in the last year, a total return since inception of 13.27%.
For those looking to make well-planned financial choices it helps to compare best sip to invest suited to long-term goals.
Rajat Srivastava
Mr. Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad
Key Metrics of Tata India Pharma & Healthcare Fund Direct-Growth
-
Standard Deviation16.55%
-
Mean19.20%
-
Sharpe Ratio0.82%
-
Alpha-3.18%
-
Beta1.01%
-
Sortino Ratio1.28%
Tata India Pharma & Healthcare Fund Direct-Growth Fund Details
|
|
Compare Mutual Funds
Tata India Pharma & Healthcare Fund Direct-Growth Fund Returns Comparison
Compare Tata India Pharma & Healthcare Fund Direct-Growth with other mutual funds in the same category
Tata India Pharma & Healthcare Fund Direct-Growth
SBI Healthcare Opportunities Fund Direct Plan-Growth
SBI Healthcare Opportunities Fund Direct Plan-IDCW
Compare more funds
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
SBI Healthcare Opportunities Fund Direct Plan-Growth  |
₹5,870 | 4.94% | 1.38% | 20.99% | 25.46% | 19.69% |
| SBI Healthcare Opportunities Fund Direct Plan-IDCW |
₹5,870 | 4.94% | 1.38% | 20.99% | 25.46% | 19.69% |
| SBI Healthcare Opportunities Fund-Growth |
₹5,870 | 4.85% | 1.13% | 19.79% | 24.17% | 18.45% |
| SBI Healthcare Opportunities Fund-IDCW |
₹5,870 | 4.85% | 1.13% | 19.79% | 24.17% | 18.45% |
| ICICI Prudential Healthcare Fund Direct-Growth |
₹6,861 | 3.40% | -1.15% | 7.63% | 22.70% | 17.19% |
| ICICI Prudential Healthcare Fund Direct-IDCW |
₹6,861 | 3.40% | -1.15% | 7.63% | 22.70% | 17.19% |
| Mirae Asset Healthcare Fund Direct-Growth |
₹3,494 | 5.10% | 3.09% | 22.03% | 24.58% | 17.02% |
| Mirae Asset Healthcare Fund Direct-IDCW |
₹3,494 | 5.10% | 3.09% | 22.03% | 24.58% | 17.02% |
| UTI Healthcare Fund Direct-Growth |
₹1,430 | 3.56% | 0.97% | 17.27% | 24.39% | 16.87% |
| UTI Healthcare Fund Direct-IDCW |
₹1,430 | 3.56% | 0.97% | 17.27% | 24.39% | 16.87% |
View More
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More funds from Tata Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Tata India Pharma & Healthcare Fund Regular-Growth
|
₹1,511 | 2.60% | -3.55% | 6.69% | 5.22% | 17.86% |
|
Tata India Pharma & Healthcare Fund Regular-IDCW
|
₹1,511 | 2.60% | -3.55% | 6.69% | 5.22% | 17.86% |
|
Tata India Pharma & Healthcare Fund Direct-IDCW
|
₹1,511 | 2.72% | -3.21% | 7.44% | 6.72% | 19.60% |
|
Tata Nifty Midsmall Healthcare Index Fund Regular-Growth
|
₹221 | 5.01% | 1.58% | 14.51% | 18.01% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Direct-Growth
|
₹221 | 5.07% | 1.74% | 14.86% | 18.73% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Regular-IDCW
|
₹221 | 5.01% | 1.58% | 14.51% | 18.01% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Direct-IDCW
|
₹221 | 5.07% | 1.74% | 14.86% | 18.73% | - |
View More
growth is based on 1-month returns of the fundsTata India Pharma & Healthcare Fund Direct-Growth Calculator
I want to invest
Pro Tip
Financial experts suggest that a person should invest 10-15% of their monthly income for long-term financial growth
/Month
I want to invest for
Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
Expected return
Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Total Investment
Wealth Gained
Total Wealth
I want to save
I want to invest for
Pro Tip
Financial experts suggest that individuals should ideally invest for a period of 5 to 10 years, or even longer, to maximize the benefits of compounding and navigate market fluctuations effectively
Years
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
Expected return
Pro Tip
Top 25% of investors consistently generate more than 12% return
% Annually
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Total Investment
Wealth Gained
Monthly Investment
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-Growth |
₹9,166 | ₹568.91 | 17.90% | 13.57% | 15.06% |
| Nippon India Pharma Fund Direct-Growth |
₹9,166 | ₹640.95 | 18.96% | 14.59% | 16.08% |
| Nippon India Pharma Fund-IDCW |
₹9,166 | ₹122.85 | 17.90% | 13.57% | 15.06% |
| Nippon India Pharma Fund Direct-IDCW |
₹9,166 | ₹175.42 | 18.96% | 14.59% | 16.08% |
| ICICI Prudential Healthcare Fund Direct-Growth |
₹6,861 | ₹47.09 | 22.70% | 17.19% | - |
| ICICI Prudential Healthcare Fund-Growth |
₹6,861 | ₹43.25 | 21.69% | 16.18% | - |
| ICICI Prudential Healthcare Fund Direct-IDCW |
₹6,861 | ₹26.43 | 22.70% | 17.19% | - |
| ICICI Prudential Healthcare Fund-IDCW |
₹6,861 | ₹23.23 | 21.69% | 16.18% | - |
| SBI Healthcare Opportunities Fund-Growth |
₹5,870 | ₹522.56 | 24.17% | 18.45% | 14.48% |
| SBI Healthcare Opportunities Fund Direct Plan-Growth |
₹5,870 | ₹606.22 | 25.46% | 19.69% | 15.73% |
View More
Top funds are based on Fund AUM
Tata India Pharma & Healthcare Fund Direct-Growth Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.92% | ₹146.17 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.43% | ₹132.02 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.43% | ₹132.02 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.43% | ₹132.02 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.43% | ₹132.02 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.43% | ₹132.02 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.43% | ₹132.02 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.87% | ₹130.76 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.38% | ₹130.11 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.03% | ₹130.01 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.03% | ₹130.01 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.59% | ₹127.09 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.59% | ₹127.09 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.34% | ₹127.07 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.66% | ₹125.61 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.51% | ₹123.89 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.51% | ₹123.89 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.51% | ₹123.89 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 8.51% | ₹123.89 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 7.99% | ₹120.84 Cr |
View More
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-Growth |
₹606.22 | 25.46% | 19.69% | - |
| SBI Healthcare Opportunities Fund Direct Plan-IDCW |
₹421.18 | 25.46% | 19.69% | - |
| SBI Healthcare Opportunities Fund-Growth |
₹522.56 | 24.17% | 18.45% | - |
| SBI Healthcare Opportunities Fund-IDCW |
₹329.19 | 24.17% | 18.45% | - |
| ICICI Prudential Healthcare Fund Direct-Growth |
₹47.09 | 22.70% | 17.19% | - |
| ICICI Prudential Healthcare Fund Direct-IDCW |
₹26.43 | 22.70% | 17.19% | - |
| Mirae Asset Healthcare Fund Direct-Growth |
₹53.16 | 24.58% | 17.02% | - |
| Mirae Asset Healthcare Fund Direct-IDCW |
₹32.02 | 24.58% | 17.02% | - |
| UTI Healthcare Fund Direct-Growth |
₹388.33 | 24.39% | 16.87% | - |
| UTI Healthcare Fund Direct-IDCW |
₹300.15 | 24.39% | 16.87% | - |
View More
growth is based on 5Y returns of the funds
Frequently Asked Questions
Tata India Pharma & Healthcare Fund Direct-Growth
What is the current AUM of Tata India Pharma & Healthcare Fund Direct-Growth?
As of Wed Sep 30, 2026, Tata India Pharma & Healthcare Fund Direct-Growth manages assets worth ₹1,511.5 crore
How has Tata India Pharma & Healthcare Fund Direct-Growth performed recently?
- 3 Months: -3.21%
- 6 Months: 7.44%
What is the long-term performance of Tata India Pharma & Healthcare Fund Direct-Growth?
- 3 Years CAGR: 19.60%
- 5 Years CAGR: 15.20%
- Since Inception: 13.27%
What is the portfolio composition of Tata India Pharma & Healthcare Fund Direct-Growth?
Equity: 99.49%, Others: 0.51%.
Who manages Tata India Pharma & Healthcare Fund Direct-Growth?
Tata India Pharma & Healthcare Fund Direct-Growth is managed by Rajat Srivastava from Tata Mutual Fund.
What is the market-cap allocation of Tata India Pharma & Healthcare Fund Direct-Growth?
Large Cap: 26.08%, Mid Cap: 34.56%, Small Cap: 39.36%.
Which are the top companies Tata India Pharma & Healthcare Fund Direct-Growth has invested in?
- Sun Pharmaceutical Industries Ltd – 10.92% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 8.43% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 8.43% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 8.43% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 8.43% of the fund's portfolio
Which are the major sectors Tata India Pharma & Healthcare Fund Direct-Growth focuses on?
- Healthcare – 182.02% of the fund's portfolio
View more FAQ's
